Pseudoporphyria
(Redirected from Pseudoporphyria cutanea tarda)
Pseudoporphyria[edit | edit source]
Pseudoporphyria is a skin condition that mimics the symptoms of porphyria, a group of disorders caused by abnormalities in the chemical steps leading to the production of heme. Unlike true porphyria, pseudoporphyria does not involve the accumulation of porphyrins in the body.
Clinical Features[edit | edit source]
Pseudoporphyria is characterized by skin changes that resemble those seen in porphyria cutanea tarda, the most common form of porphyria. These changes include:
- Photosensitivity: Increased sensitivity to sunlight, leading to skin damage.
- Blistering: Formation of blisters on sun-exposed areas, particularly the dorsal surfaces of the hands and feet.
- Scarring: Healing of blisters may result in scarring and milia formation.
- Fragile skin: The skin may become fragile and easily damaged.
Causes[edit | edit source]
Pseudoporphyria can be induced by several factors, including:
- Medications: Certain drugs, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and antibiotics, have been implicated in the development of pseudoporphyria.
- Dialysis: Patients undergoing hemodialysis for chronic kidney disease may develop pseudoporphyria.
- Ultraviolet light exposure: Excessive exposure to UV light can trigger the condition.
Diagnosis[edit | edit source]
The diagnosis of pseudoporphyria is primarily clinical, based on the characteristic skin findings and the absence of porphyrin accumulation. Laboratory tests may be performed to rule out true porphyria, including:
- Urine porphyrin analysis: To check for elevated levels of porphyrins.
- Blood tests: To assess liver function and rule out other causes of skin photosensitivity.
Treatment[edit | edit source]
Management of pseudoporphyria involves:
- Avoidance of triggering factors: Discontinuation of causative medications and protection from UV light.
- Sun protection: Use of broad-spectrum sunscreens and protective clothing.
- Wound care: Proper care of blisters to prevent infection and promote healing.
Prognosis[edit | edit source]
The prognosis for pseudoporphyria is generally good, especially when the triggering factors are identified and managed appropriately. The skin lesions may resolve over time with proper care and avoidance of further triggers.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD